Stay updated on DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial

Sign up to get notified when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record for the completed DEVOTE trial of higher-dose nusinersen in spinal muscular atrophy is displayed, including its eligibility criteria, treatment arms, outcomes, locations, and published results. Study documents and related resource links are also available.
    Difference
    100%
    Check dated 2026-11-13T10:38:23.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-30T10:38:13.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-23T10:11:32.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays an updated site revision number, from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-16T09:51:49.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-09T10:27:00.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The study record page shows a 403 Forbidden message, preventing access to the trial details.
    Difference
    0.5%
    Check dated 2026-10-02T11:17:48.000Z thumbnail image

Stay in the know with updates to DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.